Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Med Life with Dr. Horton
    • Podcasts
    • Videos
    • Alerts
    • RSS
    • Classified ads
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Activate online account
    • Look up login
    • Earn CPD Credits
    • Members Corner
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
    • Activate subscription
    • Look up login
    • Manage account
    • Manage IPs
    • View Reports
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JPN

User menu

  • Subscribe
  • My alerts
  • My Cart
  • Log in

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JPN
  • Subscribe
  • My alerts
  • My Cart
  • Log in
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Med Life with Dr. Horton
    • Podcasts
    • Videos
    • Alerts
    • RSS
    • Classified ads
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Activate online account
    • Look up login
    • Earn CPD Credits
    • Members Corner
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
    • Activate subscription
    • Look up login
    • Manage account
    • Manage IPs
    • View Reports
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Bupropion abuse and overdose

Nathan Stall, Jesse Godwin and David Juurlink
CMAJ September 16, 2014 186 (13) 1015; DOI: https://doi.org/10.1503/cmaj.131534
Nathan Stall
Department of Medicine (Stall), Divisions of Emergency Medicine and of Pharmacology and Toxicology (Godwin), University of Toronto; Institute for Clinical Evaluative Sciences (Juurlink), Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nathan.stall@mail.utoronto.ca
Jesse Godwin
Department of Medicine (Stall), Divisions of Emergency Medicine and of Pharmacology and Toxicology (Godwin), University of Toronto; Institute for Clinical Evaluative Sciences (Juurlink), Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Juurlink
Department of Medicine (Stall), Divisions of Emergency Medicine and of Pharmacology and Toxicology (Godwin), University of Toronto; Institute for Clinical Evaluative Sciences (Juurlink), Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Bupropion is a commonly used antidepressant and smoking cessation aid

Bupropion is used widely as a smoking cessation aid and antidepressant and is available in immediate- and extended-release preparations. It blocks neuronal reuptake of dopamine and norepinephrine and antagonizes acetylcholine at neuronal nicotinic receptors.1 At therapeutic doses, bupropion is generally well-tolerated; however, common adverse effects include dry mouth, nausea, agitation and insomnia.1

Bupropion abuse is a growing public health problem

Although bupropion shares some structural and pharmacologic properties with amphetamine, early research suggested the drug did not produce any psychostimulant effects.1 However, clinical experience and an increasing number of case reports describe bupropion abuse,2 including recreational ingestion, nasal insufflation of crushed tablets and, more recently, intravenous injection.3 Bupropion abusers report receiving a “high” similar to cocaine abuse, but of lesser intensity.4

Clinicians should remain vigilant for signs of bupropion misuse

Bupropion abusers report that they easily obtained the drug from physicians under the pretense of seeking an antidepressant or smoking cessation aid.3 Emerging reports also highlight bupropion misuse in correctional facilities.5 Bupropion toxicity should be considered in patients presenting with new-onset seizures of unknown cause, particularly in the context of suspected substance abuse. Nonhealing skin ulcers may reflect surreptitious injection of crushed tablets.

Seizures are a hallmark of toxicity

Bupropion lowers the seizure threshold, even at therapeutic doses of 150–450 mg/d.1 Acute overdose typically produces seizures within a few hours after ingestion, although seizure onset may be delayed up to 24 hours in patients who ingest extended-release preparations.6 The median dose associated with seizures is about 4.4 g.6 Other reported signs of toxicity include lethargy, tremor, vomiting and agitation.7 Associated cardiac toxicity includes sinus tachycardia, and massive overdose can cause widening of the QRS complex, ventricular dysrhythmias and cardiovascular collapse.8 Death can occur. Although reported data are limited, they suggest that less than 0.5% of reported cases of bupropion overdose result in death.9

Management of bupropion overdose is largely supportive

For all cases of bupropion overdose, seizures should be anticipated and a poison control centre consulted. Treatment with activated charcoal should be considered for patients presenting within 60 minutes of ingestion in whom the risk of aspiration is low.10 Whole bowel irrigation may be considered for patients with large ingestions of sustained-release preparations.11 Seizures can usually be managed with benzodiazepines alone,2 but some patients may require barbiturates or propofol.11 Phenytoin is unlikely to work and should not be administered.12 In patients with life-threatening cardiovascular toxicity, intravenous lipid emulsion may be helpful, although evidence for its use is very limited.7

CMAJ invites submissions to “Five things to know about …” Submit manuscripts online at http://mc.manuscriptcentral.com/cmaj

Footnotes

  • See references, Appendix 1, www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.131534/-/DC1

  • Competing interests: Nathan Stall is a freelance news writer for and serves on the editorial advisory board of CMAJ.

  • This article has been peer reviewed.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 186 (13)
CMAJ
Vol. 186, Issue 13
16 Sep 2014
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bupropion abuse and overdose
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
Citation Tools
Bupropion abuse and overdose
Nathan Stall, Jesse Godwin, David Juurlink
CMAJ Sep 2014, 186 (13) 1015; DOI: 10.1503/cmaj.131534

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Bupropion abuse and overdose
Nathan Stall, Jesse Godwin, David Juurlink
CMAJ Sep 2014, 186 (13) 1015; DOI: 10.1503/cmaj.131534
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Bupropion is a commonly used antidepressant and smoking cessation aid
    • Bupropion abuse is a growing public health problem
    • Clinicians should remain vigilant for signs of bupropion misuse
    • Seizures are a hallmark of toxicity
    • Management of bupropion overdose is largely supportive
    • Footnotes
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • Scopus
  • PubMed
  • Google Scholar

Cited By...

  • Effects of Repeated Treatment with Monoamine-Transporter-Inhibitor Antidepressants on Pain-Related Depression of Intracranial Self-Stimulation in Rats
  • Scopus (9)
  • Google Scholar

More in this TOC Section

  • Zollinger–Ellison syndrome
  • Benign splenic regrowth mistaken as recurrent renal cell carcinoma
  • Plastic bronchitis in a 3-year-old boy
Show more Practice

Similar Articles

Collections

  • Sections
    • Five Things to Know About
  • Topics
    • Tobacco control & smoking
    • Psychiatry & mental health: adult
    • Addiction medicine

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Videos
  • Alerts
  • RSS

Information for

  • Advertisers
  • Authors
  • CMA Members
  • Copyright and Permissions
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact

Copyright 2019, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire